Medpace Holdings, Inc. (MEDP)
599.47
+1.39
(+0.23%)
USD |
NASDAQ |
Oct 02, 16:00
599.50
+0.03
(+0.01%)
After-Hours: 20:00
Medpace Holdings Price to Book Value : 38.47 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 38.47 |
| October 01, 2026 | 38.38 |
| September 30, 2026 | 40.05 |
| September 29, 2026 | 39.92 |
| September 28, 2026 | 39.53 |
| September 25, 2026 | 39.71 |
| September 24, 2026 | 39.82 |
| September 23, 2026 | 39.60 |
| September 22, 2026 | 40.44 |
| September 21, 2026 | 40.06 |
| September 18, 2026 | 39.29 |
| September 17, 2026 | 39.48 |
| September 16, 2026 | 39.56 |
| September 15, 2026 | 39.82 |
| September 14, 2026 | 38.21 |
| September 11, 2026 | 37.70 |
| September 10, 2026 | 37.42 |
| September 09, 2026 | 37.62 |
| September 08, 2026 | 37.92 |
| September 04, 2026 | 37.94 |
| September 03, 2026 | 38.08 |
| September 02, 2026 | 38.05 |
| September 01, 2026 | 37.42 |
| August 31, 2026 | 38.12 |
| August 28, 2026 | 38.54 |
| Date | Value |
|---|---|
| August 27, 2026 | 39.24 |
| August 26, 2026 | 39.72 |
| August 25, 2026 | 39.40 |
| August 24, 2026 | 39.79 |
| August 21, 2026 | 39.83 |
| August 20, 2026 | 39.31 |
| August 19, 2026 | 39.03 |
| August 18, 2026 | 37.88 |
| August 17, 2026 | 38.32 |
| August 14, 2026 | 37.12 |
| August 13, 2026 | 37.34 |
| August 12, 2026 | 38.31 |
| August 11, 2026 | 38.86 |
| August 10, 2026 | 38.66 |
| August 07, 2026 | 37.90 |
| August 06, 2026 | 37.54 |
| August 05, 2026 | 37.72 |
| August 04, 2026 | 36.90 |
| August 03, 2026 | 36.79 |
| July 31, 2026 | 37.03 |
| July 30, 2026 | 37.11 |
| July 29, 2026 | 37.54 |
| July 28, 2026 | 36.64 |
| July 27, 2026 | 37.82 |
| July 24, 2026 | 38.59 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| IQVIA Holdings, Inc. | 6.887 |
| Charles River Laboratories International, Inc. | 4.878 |
| Avantor, Inc. | 1.843 |
| Champions Oncology, Inc. | 17.66 |
| Personalis, Inc. | 7.364 |
Price to Book Value Related Metrics
| PE Ratio | 35.16 |
| PS Ratio | 6.210 |
| PEG Ratio | 1.312 |
| Price to Free Cash Flow | 24.45 |
| Price | 599.47 |
| Earnings Yield | 2.84% |
| Market Cap | 16.69B |
| PEGY Ratio | 1.312 |
| Operating PE Ratio | 29.62 |
| Normalized PE Ratio | 35.16 |